WFA Asset Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,800
Closed -$2.41K 253
2023
Q4
$2.41K Hold
1,800
﹤0.01% 202
2023
Q3
$2.56K Hold
1,800
﹤0.01% 210
2023
Q2
$2.07K Hold
1,800
﹤0.01% 217
2023
Q1
$1.91K Hold
1,800
﹤0.01% 222
2022
Q4
$2.74K Hold
1,800
﹤0.01% 198
2022
Q3
$3.82K Hold
1,800
﹤0.01% 204
2022
Q2
$2.41K Buy
1,800
+800
+80% +$1.19K ﹤0.01% 199
2022
Q1
$2.11K Buy
+1,000
New +$2.44K ﹤0.01% 189

Other funds holding PGEN

WFA Asset Management's PGEN Position: Q1 2024 in Review

WFA Asset Management sold out of Precigen (PGEN) in Q1 2024, closing a stake of 1,800 shares — an estimated $2.41K sold.

WFA Asset Management first reported a position in PGEN in Q1 2022 and held it in 8 quarters. The position peaked at $3.82K in Q3 2022. 130 funds tracked by Wall St. Rank hold PGEN as of Q1 2024.

  • WFA Asset Management reported no remaining Precigen position as of Q1 2024 after selling out during the quarter.
  • WFA Asset Management sold 1,800 Precigen shares in Q1 2024, an estimated $2.41K.
  • WFA Asset Management first reported a position in Precigen in Q1 2022 and held it in 8 quarters.
  • WFA Asset Management's Precigen position peaked at $3.82K in Q3 2022.
  • 130 funds tracked by Wall St. Rank held Precigen as of Q1 2024.

Based on WFA Asset Management's 13F filing for Q1 2024, filed 19 Apr 2024.